ACM Research Q3 2026 Earnings Call Held; Transcript Provides No New Financial Detail

What happened

ACM Research hosted its third-quarter 2026 earnings call on November 5, 2026. The call featured management and sell-side analysts, but the provided transcript summary contains only participant names and no specific financial results or forward guidance. Based on the latest DeepValue master report, the investment debate remains centered on export-control operability, first-tool acceptance conversion, and gross-margin recovery. As of early 2026, the company guided FY2026 revenue to $1.08–$1.175B and traded near $62.64, but no update is available from this article. Investors should await the formal press release and 10-Q for actual performance against these checkpoints.

Implication

The WAIT rating from the DeepValue report remains appropriate. Until actual Q3 2026 figures show either a break below the FY2026 revenue guide or a gross margin below 42%, or conversely, evidence of first-tool inventory declining and margins above 45%, the risk-reward stays unattractive at ~34x P/E. The article adds no new catalysts, so the next 90-day checkpoint remains the formal 10-Q filing.

Thesis delta

No shift. The article only confirms that the Q3 2026 earnings call occurred with standard participants, and no new data points are available. The base-case WAIT stance, with key triggers at FY2026 revenue guide below $1.08B or Entity List shipment delays, remains unchanged.